Home
LLY
LLY News

Latest Eli Lilly and Company (LLY) News on August 26, 2025

Lilly to participate in Morgan Stanley 23rd Annual Global Healthcare Conference

PR Newswire

a day ago

Lilly to participate in Morgan Stanley 23rd Annual Global Healthcare Conference

MT Newswires

a day ago

Immuneering Partners With Eli Lilly for Lung Cancer Drug Trials

Immuneering Announces Clinical Supply Agreement with Lilly to Evaluate Atebimetinib in Combination with Olomorasib

GlobeNewswire

a day ago

Immuneering Announces Clinical Supply Agreement with Lilly to Evaluate Atebimetinib in Combination with Olomorasib

Incyclix Bio Secures $11.25 Million Series B Extension to Advance the Phase 1/2 Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors

GlobeNewswire

a day ago

Incyclix Bio Secures $11.25 Million Series B Extension to Advance the Phase 1/2 Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors

Eli Lilly (LLY) Launches Easy Mounjaro Pen in India Amid Growing Diabetes Market

Insider Monkey

a day ago

Eli Lilly (LLY) Launches Easy Mounjaro Pen in India Amid Growing Diabetes Market

The Best Stocks to Invest $50,000 in Right Now

Motley Fool

2 days ago

The Best Stocks to Invest $50,000 in Right Now

Credit Fuels the AI Boom — and Fears of a Bubble

Bloomberg

3 days ago

Credit Fuels the AI Boom — and Fears of a Bubble

Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy.

Investor's Business Daily

4 days ago

Drug Tariffs Finally Land. Why Pharma Stocks Are Breathing Easy.

AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth

Zacks

4 days ago

AbbVie Pins Hopes on Rinvoq to Drive Next Phase of Growth

Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried?

Motley Fool

4 days ago

Eli Lilly Stock Is On Track for Its Worst Performance Since 2008. Should Investors Be Worried?

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

4 days ago

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

Lilly to participate in Wells Fargo 20th Annual Healthcare Conference

PR Newswire

4 days ago

Lilly to participate in Wells Fargo 20th Annual Healthcare Conference

Is Orforglipron Pill Setback End of the Road for LLY's Obesity Plans?

Zacks

4 days ago

Is Orforglipron Pill Setback End of the Road for LLY's Obesity Plans?

MT Newswires

4 days ago

DBS Bank Adjusts Eli Lilly Price Target to $840 From $900

MT Newswires

4 days ago

Market Chatter: Novo to Cut Employee Bonuses in Denmark on Weaker Growth

Investors Crave Long-Term Debt, But Firms Don’t Want to Sell

Bloomberg

4 days ago

Investors Crave Long-Term Debt, But Firms Don’t Want to Sell

MT Newswires

5 days ago

Sector Update: Health Care Stocks Mixed Late Afternoon

Eli Lilly (LLY) Announces Retirement Of Influential Neuroscience Leader Anne White In 2025

Simply Wall St.

5 days ago

Eli Lilly (LLY) Announces Retirement Of Influential Neuroscience Leader Anne White In 2025

MT Newswires

5 days ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

MT Newswires

5 days ago

Sector Update: Health Care

Healthcare Stocks Are the Cheapest They‘ve Been in 30 Years—and a Turnaround May Have Already Started

Barrons.com

5 days ago

Healthcare Stocks Are the Cheapest They‘ve Been in 30 Years—and a Turnaround May Have Already Started

MT Newswires

5 days ago

Market Chatter: Novo Nordisk's Wegovy Demand Poised to Increase in UK as Rival Plans Price Hike

J&J to invest $2 billion to boost US manufacturing as drug tariffs loom

Reuters

5 days ago

J&J to invest $2 billion to boost US manufacturing as drug tariffs loom

Novo Nordisk Freezes Hiring in Noncritical Areas

The Wall Street Journal

5 days ago

Novo Nordisk Freezes Hiring in Noncritical Areas

Analysis-Riding high on Wegovy, Novo doubled its workforce. Now layoffs loom

Reuters

5 days ago

Analysis-Riding high on Wegovy, Novo doubled its workforce. Now layoffs loom

Guggenheim Maintains a Buy Rating on Eli Lilly and Company (LLY), Sets a $875 PT

Insider Monkey

5 days ago

Guggenheim Maintains a Buy Rating on Eli Lilly and Company (LLY), Sets a $875 PT

Jim Cramer on Novo Nordisk: “They Are Incredibly Poorly Run”

Insider Monkey

5 days ago

Jim Cramer on Novo Nordisk: “They Are Incredibly Poorly Run”

Here's Why Viking Therapeutics Bounced Back Today

Motley Fool

6 days ago

Here's Why Viking Therapeutics Bounced Back Today

Anne White to Retire as Executive Vice President and President, Lilly Neuroscience

PR Newswire

6 days ago

Anne White to Retire as Executive Vice President and President, Lilly Neuroscience

Viking Therapeutics stock plunges: Weight-loss pill trial disappoints

Yahoo Finance Video

7 days ago

Viking Therapeutics stock plunges: Weight-loss pill trial disappoints

Viking’s stock plummets on obesity pill trial results

Pharmaceutical Technology

7 days ago

Viking’s stock plummets on obesity pill trial results

Viking Therapeutics Shares Sink After Obesity Pill Data; Truist Says Sell-Off Overdone

MT Newswires

7 days ago

Viking Therapeutics Shares Sink After Obesity Pill Data; Truist Says Sell-Off Overdone

Why Novo Nordisk Stock Popped Today

Motley Fool

7 days ago

Why Novo Nordisk Stock Popped Today

Viking Therapeutics stock crashes after weight-loss pill trial shows high dropout rate

Yahoo Finance

7 days ago

Viking Therapeutics stock crashes after weight-loss pill trial shows high dropout rate

This Weight-Loss Stock Is Down 40%. It Lowers the Risks for Eli Lilly and Novo Nordisk.

Barrons.com

7 days ago

This Weight-Loss Stock Is Down 40%. It Lowers the Risks for Eli Lilly and Novo Nordisk.

Viking Therapeutics Crashes 35% On Mixed Results For Its Weight-Loss Pill

Investor's Business Daily

7 days ago

Viking Therapeutics Crashes 35% On Mixed Results For Its Weight-Loss Pill

Investing.com

7 days ago

Novo Nordisk, Eli Lilly rise after Viking obesity trial data

This Weight-Loss Stock Fell More Than 30%. What Sent It Crashing.

Barrons.com

7 days ago

This Weight-Loss Stock Fell More Than 30%. What Sent It Crashing.

Investing.com

7 days ago

Viking Therapeutics stock falls 37% on high dropout rate in obesity trial

Eli Lilly (LLY) Partners with Superluminal for AI Drug Discovery

Insider Monkey

7 days ago

Eli Lilly (LLY) Partners with Superluminal for AI Drug Discovery

Eli Lilly Just Did What Almost No One Dares in 2025

GuruFocus.com

8 days ago

Eli Lilly Just Did What Almost No One Dares in 2025

Eli Lilly Sells $6.75 Billion of Bonds in Seven-Part Deal

Bloomberg

8 days ago

Eli Lilly Sells $6.75 Billion of Bonds in Seven-Part Deal

MT Newswires

8 days ago

Sector Update: Health Care Stocks Mixed Late Afternoon

GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month

Yahoo Finance

8 days ago

GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month

Novo Nordisk, Eli Lilly, Soho House: Stocks

Yahoo Finance Video

8 days ago

Novo Nordisk, Eli Lilly, Soho House: Stocks

MT Newswires

8 days ago

Daiwa Securities Downgrades Eli Lilly to Neutral From Outperform, Cuts Price Target to $700 From $940

Novo Nordisk Stock Is Jumping. Weight-Loss Drug Wegovy Has Something to Do With It.

Barrons.com

8 days ago

Novo Nordisk Stock Is Jumping. Weight-Loss Drug Wegovy Has Something to Do With It.

Argus Research

8 days ago

Daily – Vickers Top Buyers & Sellers for 08/18/2025

Analysis: Wall Street sees new obesity pills as priced near Wegovy and Zepbound

Reuters

8 days ago

Analysis: Wall Street sees new obesity pills as priced near Wegovy and Zepbound

FDA Approves Novo Nordisk’s Wegovy for Liver Disease

The Wall Street Journal

8 days ago

FDA Approves Novo Nordisk’s Wegovy for Liver Disease

Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market

Pharma Voice

8 days ago

Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market

1 Beaten-Down Stock That Could Soar by the End of the Year

Motley Fool

9 days ago

1 Beaten-Down Stock That Could Soar by the End of the Year

Insider Buys Additional US$1.1m In Eli Lilly Stock

Simply Wall St.

9 days ago

Insider Buys Additional US$1.1m In Eli Lilly Stock

This Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for Competitors

Motley Fool

9 days ago

This Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for Competitors

3 Fantastic Growth Stocks to Buy in August

Motley Fool

9 days ago

3 Fantastic Growth Stocks to Buy in August

JPMorgan Maintains ‘Overweight’ Rating on Eli Lilly and Company (LLY) With $1,100 PT

Insider Monkey

9 days ago

JPMorgan Maintains ‘Overweight’ Rating on Eli Lilly and Company (LLY) With $1,100 PT

Eli Lilly and Company (LLY) Releases Q2 2025 Results

Insider Monkey

9 days ago

Eli Lilly and Company (LLY) Releases Q2 2025 Results

Jim Cramer Says Don't Quit Market When It's Frothy: 'Is Widespread Irrationality a Reason To Sell Down in Perfectly Rational Stocks? Absolutely Not'

Benzinga

10 days ago

Jim Cramer Says Don't Quit Market When It's Frothy: 'Is Widespread Irrationality a Reason To Sell Down in Perfectly Rational Stocks? Absolutely Not'

Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.

Motley Fool

10 days ago

Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.

Cantor Fitzgerald Slashes PT on Eli Lilly and Company (LLY) to $825 From $975

Insider Monkey

11 days ago

Cantor Fitzgerald Slashes PT on Eli Lilly and Company (LLY) to $825 From $975

Health Care Roundup: Market Talk

The Wall Street Journal

11 days ago

Health Care Roundup: Market Talk

Why Novo Nordisk Flew Almost 3% Higher on Friday

Motley Fool

11 days ago

Why Novo Nordisk Flew Almost 3% Higher on Friday

MT Newswires

11 days ago

S&P 500 Advances on Week as Likelihood of September Fed Rate-Cut Keeps Bulls Engaged

MT Newswires

11 days ago

Eli Lilly & Insider Bought Shares Worth $494,627, According to a Recent SEC Filing

Eli Lilly raising GLP-1 prices abroad raises more questions about US pricing: BofA analyst

Yahoo Finance

11 days ago

Eli Lilly raising GLP-1 prices abroad raises more questions about US pricing: BofA analyst

Why Eli Lilly (LLY) Stock Is Up Today

StockStory

11 days ago

Why Eli Lilly (LLY) Stock Is Up Today

Big Pharma Has a New Vision for Selling Drugs. It’s Going to the Mattresses.

Barrons.com

11 days ago

Big Pharma Has a New Vision for Selling Drugs. It’s Going to the Mattresses.

UK pharmacist says Eli Lilly’s Mounjaro price hike a “shock”

Pharmaceutical Technology

11 days ago

UK pharmacist says Eli Lilly’s Mounjaro price hike a “shock”

3 Stocks Estimated To Be Trading Up To 40.8% Below Their Intrinsic Value

Simply Wall St.

11 days ago

3 Stocks Estimated To Be Trading Up To 40.8% Below Their Intrinsic Value

Buffett Stock Buys Say Plenty About the Stock Market. Why His Inaction Says More.

Barrons.com

11 days ago

Buffett Stock Buys Say Plenty About the Stock Market. Why His Inaction Says More.

S&P Futures Tick Higher With Focus on U.S. Retail Sales Data and Trump-Putin Meeting

Barchart

11 days ago

S&P Futures Tick Higher With Focus on U.S. Retail Sales Data and Trump-Putin Meeting

MT Newswires

11 days ago

First Shanghai Adjusts PT on Eli Lilly and Company to $807.20 From $972.42, Maintains Buy Rating

Jim Cramer Says He is “Very Upset” With Eli Lilly

Insider Monkey

11 days ago

Jim Cramer Says He is “Very Upset” With Eli Lilly

Guidance Watch: 2 Companies Bullishly Raising Forecasts

Zacks

12 days ago

Guidance Watch: 2 Companies Bullishly Raising Forecasts

MT Newswires

12 days ago

Eli Lilly Collaborates With Superluminal Medicines on Cardiometabolic Diseases, Obesity

Goodpath Adds Self-Pay GLP-1 Option Through Integration with LillyDirect Pharmacy Provider GiftHealth

PR Newswire

12 days ago

Goodpath Adds Self-Pay GLP-1 Option Through Integration with LillyDirect Pharmacy Provider GiftHealth

Lilly signs up to $1.3 billion deal with Superluminal to develop obesity medicines

Reuters

12 days ago

Lilly signs up to $1.3 billion deal with Superluminal to develop obesity medicines

Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity

PR Newswire

12 days ago

Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity

Eli Lilly's (NYSE:LLY) Earnings Are Of Questionable Quality

Simply Wall St.

12 days ago

Eli Lilly's (NYSE:LLY) Earnings Are Of Questionable Quality

4 trends among retail investors according to Robinhood's CIO

Yahoo Finance Video

12 days ago

4 trends among retail investors according to Robinhood's CIO

Argus Research

12 days ago

Daily – Vickers Top Buyers & Sellers for 08/14/2025

Saudi Arabia Osteoporosis Drugs Market Analysis Report 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann La Roche, GlaxoSmithKline, Merck, Novartis, Pfizer, Teva Pharmaceutical, UCB

GlobeNewswire

13 days ago

Saudi Arabia Osteoporosis Drugs Market Analysis Report 2025-2033 Featuring Amgen, Eli Lilly and Co, F. Hoffmann La Roche, GlaxoSmithKline, Merck, Novartis, Pfizer, Teva Pharmaceutical, UCB

MT Newswires

13 days ago

Sector Update: Financial

Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound

Benzinga

13 days ago

Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound

MT Newswires

13 days ago

Update: Eli Lilly Launches Weight-Loss Drug Mounjaro Kwikpen in India

MT Newswires

13 days ago

Guggenheim Adjusts Price Target on Eli Lilly and Company to $875 From $942, Maintains Buy Rating

MT Newswires

13 days ago

Cantor Fitzgerald Adjusts PT on Eli Lilly and Company to $825 From $975, Maintains Overweight Rating

Argus Research

13 days ago

Daily – Vickers Top Buyers & Sellers for 08/13/2025

MT Newswires

13 days ago

Eli Lilly Reportedly Launches Weight-Loss Drug Mounjaro Kwikpen in India

If You'd Invested $1,000 in Eli Lilly (LLY) Stock 5 Years Ago, Here's How Much You'd Have Today

Motley Fool

14 days ago

If You'd Invested $1,000 in Eli Lilly (LLY) Stock 5 Years Ago, Here's How Much You'd Have Today

MT Newswires

14 days ago

Market Chatter: Eli Lilly, Pfizer Among Drugmakers Eyeing a Spot in Chinese Commercial Health Insurance Catalog

US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche

GlobeNewswire

14 days ago

US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche

LLY Q2 Deep Dive: Weight Loss Pill Data and Channel Dynamics Spur Investor Uncertainty

StockStory

14 days ago

LLY Q2 Deep Dive: Weight Loss Pill Data and Channel Dynamics Spur Investor Uncertainty

3 ways the GLP-1 market has changed shape this year

Pharma Voice

14 days ago

3 ways the GLP-1 market has changed shape this year

Puerto Rico’s ongoing journey from manufacturing hub to innovation enterprise

Pharma Voice

14 days ago

Puerto Rico’s ongoing journey from manufacturing hub to innovation enterprise

Lilly’s Mounjaro Exhibits Heart Benefits In Type 2 Diabetes Landmark Trial

Insider Monkey

15 days ago

Lilly’s Mounjaro Exhibits Heart Benefits In Type 2 Diabetes Landmark Trial

PRIMECAP Management's Strategic Moves: Significant Reduction in Eli Lilly and Co

GuruFocus.com

15 days ago

PRIMECAP Management's Strategic Moves: Significant Reduction in Eli Lilly and Co

Find Oversold Stocks to Buy at a Discount With This Barchart Screener

Barchart

15 days ago

Find Oversold Stocks to Buy at a Discount With This Barchart Screener

MT Newswires

15 days ago

Deutsche Bank Adjusts Eli Lilly Price Target to $900 From $1,010, Maintains Buy Rating

Leerink Downgrades Eli Lilly and Company (LLY) to Market Perform From Outperform

Insider Monkey

15 days ago

Leerink Downgrades Eli Lilly and Company (LLY) to Market Perform From Outperform

Share on Social Networks: